Aurora Cannabis Inc (ACB) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.030x

Based on the latest financial reports, Aurora Cannabis Inc (ACB) has a cash flow conversion efficiency ratio of 0.030x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$17.00 Million ≈ $12.30 Million USD) by net assets (CA$567.83 Million ≈ $410.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ACB equity financing ratio to measure how much of total assets are equity-financed.

Aurora Cannabis Inc - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Aurora Cannabis Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Aurora Cannabis Inc (ACB) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Aurora Cannabis Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Aurora Cannabis Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
FIGX Capital Acquisition Corp. Class A Ordinary Share
NASDAQ:FIGX
0.000x
Humax Co. Ltd
KQ:115160
-0.018x
Mikro MSC Bhd
KLSE:0112
0.019x
Novonix Ltd ADR
NASDAQ:NVX
-0.160x
Piedmont Lithium Ltd ADR
NASDAQ:PLL
-0.008x
Thryv Holdings Inc
NASDAQ:THRY
0.101x
Federal Agricultural Mortgage Corporation
NYSE:AGM-A
0.054x
Indo Rama Synthetics (India) Limited
NSE:INDORAMA
0.176x

Annual Cash Flow Conversion Efficiency for Aurora Cannabis Inc (2007–2025)

The table below shows the annual cash flow conversion efficiency of Aurora Cannabis Inc from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see Aurora Cannabis Inc (ACB) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 CA$608.59 Million
≈ $440.25 Million
CA$16.00 Million
≈ $11.58 Million
0.026x +123.10%
2024-03-31 CA$601.87 Million
≈ $435.38 Million
CA$-68.51 Million
≈ $-49.56 Million
-0.114x +49.18%
2023-03-31 CA$517.14 Million
≈ $374.09 Million
CA$-115.82 Million
≈ $-83.78 Million
-0.224x -34.53%
2022-03-31 CA$662.35 Million
≈ $479.14 Million
CA$-110.27 Million
≈ $-79.77 Million
-0.166x -61.10%
2021-03-31 CA$2.04 Billion
≈ $1.47 Billion
CA$-210.58 Million
≈ $-152.33 Million
-0.103x +35.77%
2020-03-31 CA$2.13 Billion
≈ $1.54 Billion
CA$-342.14 Million
≈ $-247.50 Million
-0.161x -267.42%
2019-03-31 CA$4.39 Billion
≈ $3.18 Billion
CA$-192.25 Million
≈ $-139.07 Million
-0.044x +16.18%
2018-03-31 CA$1.56 Billion
≈ $1.13 Billion
CA$-81.67 Million
≈ $-59.08 Million
-0.052x +14.50%
2017-03-31 CA$218.93 Million
≈ $158.37 Million
CA$-13.38 Million
≈ $-9.68 Million
-0.061x +94.62%
2016-03-31 CA$5.96 Million
≈ $4.31 Million
CA$-6.77 Million
≈ $-4.90 Million
-1.136x -30.96%
2015-03-31 CA$3.83 Million
≈ $2.77 Million
CA$-3.32 Million
≈ $-2.40 Million
-0.867x -21.62%
2014-03-31 CA$1.35 Million
≈ $979.00K
CA$-965.11K
≈ $-698.14K
-0.713x -10.54%
2013-03-31 CA$694.20K
≈ $502.17K
CA$-447.84K
≈ $-323.96K
-0.645x -149.38%
2012-03-31 CA$1.07 Million
≈ $777.31K
CA$-277.98K
≈ $-201.09K
-0.259x -28.90%
2011-03-31 CA$1.37 Million
≈ $992.94K
CA$-275.48K
≈ $-199.28K
-0.201x -11055.39%
2010-03-31 CA$1.71 Million
≈ $1.24 Million
CA$-3.08K
≈ $-2.23K
-0.002x +92.54%
2009-03-31 CA$1.62 Million
≈ $1.17 Million
CA$-39.04K
≈ $-28.24K
-0.024x +53.43%
2008-03-31 CA$1.69 Million
≈ $1.22 Million
CA$-87.26K
≈ $-63.12K
-0.052x -247.38%
2007-03-31 CA$430.22K
≈ $311.22K
CA$15.11K
≈ $10.93K
0.035x --

About Aurora Cannabis Inc

TO:ACB Canada Drug Manufacturers - Specialty & Generic
Market Cap
$159.17 Million
CA$220.03 Million CAD
Market Cap Rank
#17356 Global
#551 in Canada
Share Price
CA$3.88
Change (1 day)
-2.02%
52-Week Range
CA$3.64 - CA$8.66
All Time High
CA$1808.40
About

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers pharmaceutical-grade cannabis products; medical and consumer cannabis products; and engages in the propagation of vegetables … Read more